Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Targeted Supradose Cisplatin Chemoradiation for Stage IV Head and Neck Cancer
NCT00002932Phase 2Completed
- Sponsor
- NRG Oncology
- Start
- May 1997
- Primary completion
- Mar 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin in squamous cell carcinoma of the head and neck (HNSCC), sponsored by NRG Oncology. Started May 1997; status: completed.
02
Drugs
cisplatin
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00002932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002932.